Ponce, Pilar, NONE. S.
HRN: 04-43-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2022
CO-AMOXICLAV 625MG (TAB)
10/29/2022
11/04/2022
PO
625mg
Q8
Complicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes